SCHEMBL1551340

SCHEMBL1551340

CC/C=C\C/C=C\C/C=C\C/C=C\CCS

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
CYP19A1 P11511 4/20 0.48
PPARG P37231 3/20 0.48
OXER1 Q8TDS5 3/20 0.48
MAPT P10636 3/20 0.48
RXRA P19793 2/20 0.48
FFAR1 O14842 2/20 0.48
PTGS1 P23219 4/20 0.45
F7 P08709 3/20 0.45
F3 P13726 3/20 0.45
PPARA Q07869 3/20 0.45
KMT2A Q03164 2/20 0.45
PPARD Q03181 2/20 0.45
ADORA3 P0DMS8 2/20 0.45
NR1I2 O75469 2/20 0.42
PTGS2 P35354 2/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TDP1 Q9NUW8 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1551344 1.00 ALDH1A1 (0.48) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL17798939 1.00 ALDH1A1 (0.48) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL17798937 1.00 ALDH1A1 (0.48) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL10368503 0.91
SCHEMBL126838 0.91
SCHEMBL10366683 0.91
SCHEMBL1551395 0.82 ALDH1A1 (0.52) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL3803268 0.82 ALDH1A1 (0.52) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL3803270 0.82 ALDH1A1 (0.52) ALDH1A1CYP19A1PPARGOXER1MAPT
SCHEMBL19686813 0.82 ALDH1A1 (0.52) ALDH1A1CYP19A1PPARGOXER1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383380-B1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE BIOZEP AS (NO) 2023-01-04 EP disclosed
US-20190284129-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE BIOZEP AS (NO) 2019-09-19 US disclosed
US-20180346408-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE BIOZEP AS (NO) 2018-12-06 US disclosed
EP-3383380-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE Biozep AS (NO) 2018-10-10 EP disclosed
WO-2017093732-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE BIOZEP AS (NO) 2017-06-08 WO disclosed
US-20170029368-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS 2017-02-02 US disclosed
US-20170029368-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS 2017-02-02 US disclosed
US-20170029368-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS 2017-02-02 US disclosed
EP-2313090-B1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2016-03-30 EP disclosed
EP-2313090-B1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2016-03-30 EP disclosed
US-8759558-B2 Sulphur containing lipids for use as food supplement or as medicament PRONOVA BIOPHARMA NORGE AS (NO) 2014-06-24 US disclosed
US-8759558-B2 Sulphur containing lipids for use as food supplement or as medicament PRONOVA BIOPHARMA NORGE AS (NO) 2014-06-24 US disclosed
US-20110190395-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2011-08-04 US disclosed
US-20110190395-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2011-08-04 US disclosed
US-20110190395-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2011-08-04 US disclosed
EP-2313090-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT Pronova BioPharma Norge AS (NO) 2011-04-27 EP disclosed
EP-2147910-A1 Novel lipid compounds Pronova BioPharma Norge AS (NO) 2010-01-27 EP disclosed
EP-2147910-A1 Novel lipid compounds Pronova BioPharma Norge AS (NO) 2010-01-27 EP disclosed
WO-2010008299-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2010-01-21 WO disclosed
WO-2010008299-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2010-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170029368-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT SGMS2, SGMS1, FABP2 ALDH1A1 472/4885CYP19A1 3183/4885PPARG 202/4885
US-20110190395-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT SGMS2, SGMS1, ACSS2 ALDH1A1 514/4885CYP19A1 2818/4885PPARG 217/4885
US-20190284129-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE APOB, ALOX12, NR1H2 ALDH1A1 417/4885CYP19A1 884/4885PPARG 392/4885
US-20180346408-A1 LIPID COMPOUNDS AND COMPOSITIONS AND THEIR OPTHALMIC USE NR1H2, NR1H3, APOB ALDH1A1 618/4885CYP19A1 1093/4885PPARG 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.